Fence Spikes Uk

Acid Extractable Matrix Spikes

CLPS-MSA15-TI 1ML
EUR 52.8

Human IgG antibody Laboratories manufactures the fence spikes uk reagents distributed by Genprice. The Fence Spikes Uk reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Spike S. Other Fence products are available in stock. Specificity: Fence Category: Spikes Group: Uk

JBS True Blue

300µl
EUR 13.7

Human True insulin ELISA kit

192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Human True insulin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human True insulin ELISA kit

1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Human True insulin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human True insulin ELISA kit

1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Human True insulin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human True Insulin GENLISA ELISA

1 x 96 wells
EUR 286

Human True insulin ELISA kit

96T
EUR 700
Description: ELISA

UK-5099

each
EUR 652.8

Uk information

SARS-CoV-2 Spike B.1.1.7 Mutation RBD Domain (UK Variant, 100ug)

BSV-COV-PR-72 100 ug Ask for price
Description: SARS-CoV-2 Spike B.1.1.7 Mutation RBD Domain (UK Variant, 100ug)

SARS-CoV-2 full-length Trimeric Spike Antigen (UK Variant, 1mg)

BSV-COV-PR-67 1mg Ask for price
Description: SARS-CoV-2 full-length Trimeric Spike Recombinant Protein (UK Variant, >1mg)

SARS-CoV-2 full-length Trimeric Spike Antigen (UK Variant, 100ug)

BSV-COV-PR-65 100 ug Ask for price
Description: SARS-CoV-2 full-length Trimeric Spike Recombinant Protein (UK Variant, 100ug)

SARS-CoV-2 full-length Trimeric Spike Antigen (UK Variant, 10mg)

BSV-COV-PR-89 10 mg Ask for price
Description: SARS-CoV-2 full-length Trimeric Spike Antigen (UK Variant, 10mg)

SARS-CoV-2 (COVID-19) Alpha Variant (B.1.1.7, UK) Spike P681H Peptide

9359P 0.05 mg
EUR 235.5
Description: SARS-CoV-2 (COVID-19) Alpha Variant (B.1.1.7, UK) Spike P681H Peptide

SARS-CoV-2 full-length Trimeric Spike Antigen (UK/Nigerian Variant, 100ug)

BSV-COV-PR-79 100 ug Ask for price
Description: SARS-CoV-2 full-length Trimeric Spike Antigen (UK/Nigerian Variant, 100ug)

SARS-CoV-2 full-length Trimeric Spike Antigen (UK/Nigerian Variant, 1mg)

BSV-COV-PR-86 1 mg Ask for price
Description: SARS-CoV-2 full-length Trimeric Spike Antigen (UK/Nigerian Variant, 1mg)

SARS-CoV-2 full-length Trimeric Spike Antigen (UK/Nigerian Variant, 10mg)

BSV-COV-PR-87 10 mg Ask for price
Description: SARS-CoV-2 full-length Trimeric Spike Antigen (UK/Nigerian Variant, 10mg)

SARS-CoV-2 (COVID-19) UK variant (B.1.1.7) Spike S1 (N501Y) Recombinant Protein

11-084 0.1 mg
EUR 651.3
Description: A new variant of SARS-CoV-2 is spreading in the UK and is rapidly becoming a global threat. It ischaracterized by multiple mutations in the spike protein. Among them, N501Y is of major concernbecause it involves one of the six key amino acid residues determining a tight interaction of theSARS-CoV-2 receptor-binding domain (RBD) with its cellular receptor angiotensin-converting enzyme2 (ACE2).

SARS-CoV-2 (COVID-19) Alpha Variant (B.1.1.7, UK) Spike RBD Recombinant Protein

21-824 0.1 mg
EUR 1186.8
Description: All viruses undergo fast mutations and adept quickly to the countermeasures that the immune systems creates against them. SARS-CoV-2 of the COVID-19 pandemic is no exception here. During the pandemic multiple mutant strains arose. To help the science combat these mutants ProSci offers the RB-Domains of these mutant SPIKE proteins. That is the full RBD domain of the SPIKE surface protein SARS-CoV-2 of the mutant strain B.1.1.7, also commonly known as the "UK / Great Britain mutant".

OPSN00004-100UG - SARS-CoV-2 Spike RBD N501Y (UK Variant Alpha) Recombinant Protein

OPSN00004-100UG 100ug
EUR 370

SARS-CoV-2 (COVID-19) Full-Length Eta Variant (B.1.525, UK) Spike Recombinant Protein

21-821 0.025 mg
EUR 796.2
Description: All viruses undergo fast mutations and adapt quickly to the countermeasures that the immune systems creates. SARS-CoV-2 of the COVID-19 pandemic is no exception to this. During the pandemic multiple mutant strains arose. To help the sciencific community to combat these mutants ProSci offers the SPIKE protein of the mutants in full-length and active in their native trimeric form, stabilized with the LMNG detergent. This is the SPIKE protein of the mutant strain B.1.525.

SARS-CoV-2 (COVID-19) Alpha Variant (B.1.1.7, UK) Spike S1 (RBD) Recombinant Protein

21-808 50 ug
EUR 619.8
Description: SARS-CoV-2 shares 79.5% sequence identity with SARS-CoV and is 96.2% identical at the genome level to the bat coronavirus BatCoV RaTG133, suggesting it had originated in bats. The coronaviral genome encodes four major structural proteins: the Spike (S) protein, Nucleocapsid (N) protein, Membrane/Matrix (M) protein and the Envelope (E) protein. The SARS Envelope (E) protein contains a short palindromic transmembrane helical hairpin that seems to deform lipid bilayers, which may explain its role in viral budding and virion envelope morphogenesis. The SARS Membrane/Matrix (M) protein is one of the major structural viral proteins. It is an integral membrane protein involved in the budding of the viral particles and interacts with SARS Spike (S) protein and the Nucleocapsid (N) protein. The N protein contains two domains, both of them bind the virus RNA genome via different mechanisms.The CoV Spike (S) protein assembles as trimer and plays the most important role in viral attachment, fusion and entry. It is composed of a short intracellular tail, a transmembrane anchor and a large ectodomain that consists of a receptor binding S1 subunit (RBD domain) and a membrane-fusing S2 subunit. The S1 subunit contains a receptor binding domain (RBD), which binds to the cell surface receptor angiotensin-converting enzyme 2 (ACE2) present at the surface of epithelial cells. Recently, a more transmissible variant of SARS-CoV-2, called B.1.1.7, was detected in the south of England. This variant carries a mutation in the RBD at the position 501 (N501Y).

SARS-CoV-2 (COVID-19) Alpha Variant (B.1.1.7, UK) Spike S1 (RBD) Recombinant Protein

21-811 50 ug
EUR 537.9
Description: SARS-CoV-2 shares 79.5% sequence identity with SARS-CoV and is 96.2% identical at the genome level to the bat coronavirus BatCoV RaTG133, suggesting it had originated in bats. The coronaviral genome encodes four major structural proteins: the Spike (S) protein, Nucleocapsid (N) protein, Membrane/Matrix (M) protein and the Envelope (E) protein. The SARS Envelope (E) protein contains a short palindromic transmembrane helical hairpin that seems to deform lipid bilayers, which may explain its role in viral budding and virion envelope morphogenesis. The SARS Membrane/Matrix (M) protein is one of the major structural viral proteins. It is an integral membrane protein involved in the budding of the viral particles and interacts with SARS Spike (S) protein and the Nucleocapsid (N) protein. The N protein contains two domains, both of them bind the virus RNA genome via different mechanisms.The CoV Spike (S) protein assembles as trimer and plays the most important role in viral attachment, fusion and entry. It is composed of a short intracellular tail, a transmembrane anchor and a large ectodomain that consists of a receptor binding S1 subunit (RBD domain) and a membrane-fusing S2 subunit. The S1 subunit contains a receptor binding domain (RBD), which binds to the cell surface receptor angiotensin-converting enzyme 2 (ACE2) present at the surface of epithelial cells. Recently, a more transmissible variant of SARS-CoV-2, called B.1.1.7, was detected in the south of England. This variant carries a mutation in the RBD at the position 501 (N501Y).The SARS-CoV-2 Spike Protein S1 (RBD) (rec.) (His) (B.1.1.7 Variant, UK) can be used as antigen in Serological ELISA Kits to detect anti-SARS-CoV-2 Spike (RBD) antibodies in serum or plasma.

SARS-CoV-2 (COVID-19) Full-Length Alpha Variant (B.1.1.7, UK) Spike Recombinant Protein

21-818 0.025 mg
EUR 796.2
Description: All viruses undergo fast mutations and adapt quickly to the countermeasures that the immune systems creates. SARS-CoV-2 of the COVID-19 pandemic is no exception to this. During the pandemic multiple mutant strains arose. To help the sciencific community to combat these mutants ProSci offers the SPIKE protein of the mutants in full-length and active in their native trimeric form, stabilized with the LMNG detergent.; This is the spike protein of the mutant strain B.1.1.7, also commonly known as the "UK / Great Britain mutant".

SARS-CoV-2 (COVID-19) UK variant (B.1.1.7) Spike S1 (N501Y) Recombinant Protein His-Avi Lyophilized

ICOV2UKB117SPIKES1N501YRHISAVILY100UG each
EUR 762
Description: SARS-CoV-2 (COVID-19) UK variant (B.1.1.7) Spike S1 (N501Y) Recombinant Protein His-Avi Lyophilized

GENLISA Human SARS-CoV-2 spike protein RBD mutation N501Y (UK/South Africa/Brazil variant) Quantitative TITRATION ELISA

KBVH015-36_ 1 x 96 wells
EUR 660